CUBN and COVID-19: As already established for other viral infections, determining anti-SARS-CoV-2 Igs is important for evaluating recovery of hospitalized patients from COVID-19, but is also the method-of-choice for evaluating SARS-CoV-2 seroprevalence in a given population [7].